Susceptibility of the different developmental stages of the asexual (schizogonic) erythrocyte cycle of Plasmodium chabaudi chabaudi to hyperimmune serum, immunoglobulin (Ig)G1, IgG2a and F(ab′)2 fragments

Parasite Immunology

Volumn 23, Issue 11, 2001, Pages 587-597

  Cavinato, Regiane A ^a   Bastos, Karina R B ^a   Sardinha, Luiz R ^a   Elias, Rosa M ^a   Alvarez, José M ^a   D'Império Lima, Maria Regina ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antibody treatment; Malaria; Passive immunization; Plasmodium chabaudi

Indexed keywords

COBROTOXIN; HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A;

ANIMAL MODEL; ARTICLE; CELL CYCLE; COMPLEMENT SYSTEM; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; FEMALE; FLOW CYTOMETRY; INOCULATION; LYSIS; MEROZOITE; MOUSE; NONHUMAN; PARASITEMIA; PASSIVE IMMUNIZATION; PHAGOCYTOSIS; PLASMODIUM CHABAUDI; PRIORITY JOURNAL; SCHIZONT; TROPHOZOITE;

ANIMALS; ANTIBODIES, PROTOZOAN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ERYTHROCYTES; FEMALE; IMMUNE SERA; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN G; LIFE CYCLE STAGES; MALARIA; MICE; MICE, INBRED BALB C; PARASITEMIA; PLASMODIUM CHABAUDI; TIME FACTORS;

ANIMALIA; MURINAE; PLASMODIUM CHABAUDI; PLASMODIUM CHABAUDI CHABAUDI; PROTOZOA;

EID: 0035723806     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3024.2001.00419.x     Document Type: Article

References (41)

1. Gamma-globulin and acquired immunity to human malaria
2. Treatment of East African Plasmodium falciparum malaria with West African human gammaglobulin
3. Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria
4. Immune effector mechanisms in malaria
5. Plasmodium yoelii: Antibody and the maintenance of immunity in BALB/c mice
6. Protective immune response to Plasmodium chabaudi, developed by mice after drug controlled infection or vaccination with parasite extracts: Analysis of stage specific antigens from the asexual blood cycle
7. Protective immunity to malaria. Studies with cloned lines of Plasmodium chabaudi chabaudi and P. berghei in CBA/Ca mice. II. The effectiveness and inter- or intra-species specificity of the passive transfer of immunity with serum
8. Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria
9. Passive immunization with antibodies against three distinct epitopes on Plasmodium yoelii merozoite surface protein 1 suppresses parasitemia
10. Plasmodium: Immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge
11. Plasmodium berghei: Adherence and phagocytosis by rat macrophages in vitro
12. Serum opsonic activity in rodent malaria: Functional and immunochemical characteristics in vitro
13. Immune phagocytosis in murine malaria
14. Acute Plasmodium chabaudi chabaudi malaria infection induces antibodies which bind to the surfaces of parasitized erythrocytes and promote their phagocytosis by macrophages in vitro
15. Humoral immunity in rodent malaria. III: Studies on the site of antibody action
16. Plasmodium chabaudi: A rodent malaria model for in-vivo and in-vitro cytoadherence of malaria parasites in the absence of knobs
17. Relationships between sequestration, antigenic variation and chronic parasitism in Plasmodium chabaudi chabaudi - A rodent malaria model
18. Plasmodium chabaudi-infected erythrocytes adhere to CD36 and bind to microvascular endothelial cells in an organ-specific way
19. Fc receptors are not required for antibody-mediated protection against lethal malaria challenge in a mouse
20. Immunoglobulin G3 antibodies specific for the 19-kilodalton carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein 1 transfer protection to mice deficient in Fc-gamma RI receptors
21. Antimalarial antibodies in the immunoglobulin G2a isotype modulate parasitemias in mice infected with Plasmodium yoelii
22. Interferon-gamma and the induction of protective IgG2a antibodies in non-lethal Plasmodium berghei infection of mice
23. Distribution of immunoglobulin isotypes in the nonspecific B-cell response induced by infection with Plasmodium chabaudi adami and Plasmodium yoelii
24. Isotypic pattern of the polyclonal B cell response during primary infection by Plasmodium chabaudi and in immune-protected mice
25. + spleen cells
26. Tumor necrosis factor alpha p55 receptor is important for development of memory responses to blood-stage malaria infection
27. Chronobiology of Plasmodium chabaudi chabaudi: Analysis of hourly recorded total and differential parasitaemia during schizogonic cycle
28. Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose
29. The isotype composition and avidity of naturally acquired anti-Plasmodium falciparum antibodies: Differential patterns in clinically immune africans and amazonian patients
30. In vivo anti-complementary activities of the cobra venom factors from Naja naja and Naja haje
31. Erythrocyte membrane-associated immunoglobulins during malaria infection of mice
32. Plasmodium chabaudi: Antigenic variation during recrudescent parasitaemia in mice
33. Malaria parasites undergo antigenic variation at high rates in vivo
34. Antibody recognition of rodent malaria parasite antigens exposed at the infected erythrocyte surface: Specificity of immunity generated in hyperimmune mice
35. Protective monoclonal antibodies recognizing stage-specific merozoite antigens of a rodent malaria parasite
36. The role of Th1 and Th2 cells in rodent malaria infection
37. Schistosoma mansoni: In vitro and in vivo killing of antibody-coated schistosomula
38. The effect of C3 depletion on clearance of Trypanosoma cruzi induced by IgG antibodies
39. Immune mechanism facilitating clearance of Trypanosoma gambiense by IgG3 antibody from infected host
40. Complement does not facilitate plasmodial infections
41. Serum complement and immunity in experimental simian malaria. II. Preferential activation of early components and failure of depletion of late components to inhibit protective immunity